Immunoprecise Antibodies Ltd
IPA2.070USD
0.000
Cierre 11/04, 16:00（ET）Cotizaciones retrasadas 15 min
95.54MCap. mercado
PérdidaP/E TTM
Más Datos de Immunoprecise Antibodies Ltd Compañía
ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.
Información de Immunoprecise Antibodies Ltd
Símbolo de cotizaciónIPA
Nombre de la empresaImmunoprecise Antibodies Ltd
Fecha de salida a bolsaJan 30, 1987
Director ejecutivoDr. Jennifer Lynne Bath, Ph.D.
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalJan 30
DirecciónIndustrious 823 Congress Ave Suite 300
CiudadAUSTIN
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal78701
Teléfono16048060626
Sitio Webhttps://www.ipatherapeutics.com/
Símbolo de cotizaciónIPA
Fecha de salida a bolsaJan 30, 1987
Director ejecutivoDr. Jennifer Lynne Bath, Ph.D.
Ejecutivos de Immunoprecise Antibodies Ltd
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Jennifer Lynne Bath, Ph.D.
Dr. Jennifer Lynne Bath, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
498.12K
--
Dr. Kamil Isaev
Dr. Kamil Isaev
Director
Director
3.19K
--
Mr. Dirk Witters
Mr. Dirk Witters
Independent Director
Independent Director
1.95K
--
Ms. Kari Graber
Ms. Kari Graber
Vice President - Commercial Services
Vice President - Commercial Services
700.00
--
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Director
Director
--
--
Dr. Ilse Roodink, Ph.D.
Dr. Ilse Roodink, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Barry A. Springer
Mr. Barry A. Springer
Independent Director
Independent Director
--
--
Mr. Joseph Scheffler
Mr. Joseph Scheffler
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Jennifer Lynne Bath, Ph.D.
Dr. Jennifer Lynne Bath, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
498.12K
--
Dr. Kamil Isaev
Dr. Kamil Isaev
Director
Director
3.19K
--
Mr. Dirk Witters
Mr. Dirk Witters
Independent Director
Independent Director
1.95K
--
Ms. Kari Graber
Ms. Kari Graber
Vice President - Commercial Services
Vice President - Commercial Services
700.00
--
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Director
Director
--
--
Dr. Ilse Roodink, Ph.D.
Dr. Ilse Roodink, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
Por negocioUSD
Nombre
Ganancia
Proporción
Project revenue
3.13M
98.89%
Cryo storage revenue
33.00K
1.04%
Product sales revenue
2.00K
0.06%
Por regiónUSD
Nombre
Ganancia
Proporción
United States of America
2.45M
77.48%
Europe
520.00K
16.45%
Canada
174.00K
5.50%
Australia
18.00K
0.57%
Other
0.00
0.00%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Project revenue
3.13M
98.89%
Cryo storage revenue
33.00K
1.04%
Product sales revenue
2.00K
0.06%
Estadísticas de accionistas
Actualizado: dom., 14 de sep
Actualizado: dom., 14 de sep
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Charmquark TWEE
7.92%
Ingalls & Snyder LLC (Asset Management)
6.02%
Susquehanna International Group, LLP
1.51%
Bath (Jennifer Lynne)
1.08%
XTX Markets LLC
0.20%
Otro
83.26%
Accionistas
Accionistas
Proporción
Charmquark TWEE
7.92%
Ingalls & Snyder LLC (Asset Management)
6.02%
Susquehanna International Group, LLP
1.51%
Bath (Jennifer Lynne)
1.08%
XTX Markets LLC
0.20%
Otro
83.26%
Tipos de accionistas
Accionistas
Proporción
Corporation
7.92%
Investment Advisor/Hedge Fund
6.11%
Investment Advisor
1.71%
Individual Investor
1.23%
Research Firm
0.30%
Hedge Fund
0.28%
Venture Capital
0.20%
Family Office
0.04%
Otro
82.21%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
40
3.97M
8.60%
-183.07K
2025Q2
46
8.16M
23.11%
+1.40M
2025Q1
45
6.32M
13.81%
+742.61K
2024Q4
45
4.34M
9.53%
-1.30M
2024Q3
46
5.39M
19.68%
+72.87K
2024Q2
48
5.12M
19.96%
-156.62K
2024Q1
50
5.14M
20.20%
-196.19K
2023Q4
58
5.33M
20.96%
+124.72K
2023Q3
50
4.91M
19.67%
-438.42K
2023Q2
53
5.01M
20.08%
-885.29K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Charmquark TWEE
3.66M
7.92%
--
--
Jul 25, 2025
Ingalls & Snyder LLC (Asset Management)
2.78M
6.02%
+21.24K
+0.77%
Jun 30, 2025
Susquehanna International Group, LLP
699.24K
1.51%
-3.76K
-0.53%
Jun 30, 2025
Bath (Jennifer Lynne)
498.12K
1.08%
--
--
Aug 27, 2025
XTX Markets LLC
91.38K
0.2%
+72.90K
+394.36%
Jun 30, 2025
Two Sigma Investments, LP
90.86K
0.2%
+273.00
+0.30%
Jun 30, 2025
CIBC World Markets Inc.
41.20K
0.09%
--
--
Jun 30, 2025
Renaissance Technologies LLC
40.48K
0.09%
+11.08K
+37.69%
Jun 30, 2025
Levine (Mitchell S)
30.00K
0.07%
+10.00K
+50.00%
Aug 01, 2024
Virtu Americas LLC
28.92K
0.06%
-28.92K
-50.00%
Jun 30, 2025
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
